🇺🇸 mometasone furoate and formoterol in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 8

Most-reported reactions

1. Adrenal Insufficiency — 1 report (12.5%)
2. Asthma — 1 report (12.5%)
3. Cardiac Failure — 1 report (12.5%)
4. Drug Ineffective — 1 report (12.5%)
5. Dyspnoea — 1 report (12.5%)
6. Interstitial Lung Disease — 1 report (12.5%)
7. Lymphopenia — 1 report (12.5%)
8. Pneumocystis Jirovecii Pneumonia — 1 report (12.5%)

Source database →

Frequently asked questions

Is mometasone furoate and formoterol approved in United States?

mometasone furoate and formoterol does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for mometasone furoate and formoterol in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.